Smart responsive nanoplatform via in situ forming disulfiram-copper ion chelation complex for cancer combination chemotherapy
Autor: | Liming Zhang, Zhifei Wang, Kaiying Jia, Xiangyu Meng, Kai Sun |
---|---|
Rok vydání: | 2021 |
Předmět: |
Tumor microenvironment
Chemistry General Chemical Engineering Combination chemotherapy 02 engineering and technology General Chemistry 010402 general chemistry 021001 nanoscience & nanotechnology 01 natural sciences Combinatorial chemistry Industrial and Manufacturing Engineering In vitro 0104 chemical sciences In vivo Disulfiram Toxicity medicine Environmental Chemistry Doxorubicin Chelation 0210 nano-technology medicine.drug |
Zdroj: | Chemical Engineering Journal. 415:128947 |
ISSN: | 1385-8947 |
DOI: | 10.1016/j.cej.2021.128947 |
Popis: | Smart responsive nanomedicines serving as carriers can take advantage of the specific tumor microenvironment (TME) to convert non-toxic drugs into effective anticarcinogens and release chemotherapeutic drugs in situ to improve therapeutic efficiency against tumors without inducing off-target toxicity to surrounding normal tissues/cells. Herein, a pH-responsive metal-organic framework nanoparticle is constructed by encapsulating disulfiram (DSF) and doxorubicin (DOX) into the zeolitic imidazolate framework-8 (ZIF-8) and then coating with copper ion (Cu2+)-tannic acid (TA) complex (denoted as DSF/DOX@ZIF-8@Cu-TA) to achieve enhanced combination chemotherapy. The release of Cu2+ from the outer shell of DSF/DOX@ZIF-8@Cu-TA and the cooperative exposure of DSF and DOX are triggered at multiple stages by mild acidity TME. The accumulation of DSF (non-toxic drugs) and Cu2+ results in the rapid formation of high cytotoxic bis(N, N-diethyl dithiocarbamato)-Cu2+ complexes (CuL2) in situ via DSF and Cu2+ chelating reaction, which accompany the production of ROS via Cu+-based Fenton-like reaction. Besides, the anticancer effect of DOX is augmented by CuL2-modulated ROS-MAPK and NF-κB signal pathways. The constructed DSF/DOX@ZIF-8@Cu-TA present significantly improved therapeutic efficiency as demonstrated both in vitro and in vivo. The strategy of nontoxicity-to-toxicity transitions with the addictive effect of chemotherapeutics provides a promising paradigm to design novel nanoplatforms for synergistic cancer chemotherapy. |
Databáze: | OpenAIRE |
Externí odkaz: |